BI D1870

AKT serine/threonine kinase 1 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35328342 The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma. 2022 Mar 8 1
2 32420699 Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. 2020 Jul 1